RCAMU
Rothschild & Co Asset Management US’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-734,267
| Closed | -$17.4M | – | 365 |
|
|
2019
Q4 | $17.4M | Sell |
734,267
-36,695
| -5% | -$870K | 0.18% | 205 |
|
|
2019
Q3 | $21.2M | Sell |
770,962
-10,964
| -1% | -$301K | 0.23% | 183 |
|
|
2019
Q2 | $25.9M | Sell |
781,926
-66,873
| -8% | -$2.21M | 0.28% | 156 |
|
|
2019
Q1 | $29.7M | Sell |
848,799
-2,684
| -0.3% | -$94K | 0.32% | 117 |
|
|
2018
Q4 | $28.3M | Buy |
851,483
+15,455
| +2% | +$513K | 0.34% | 107 |
|
|
2018
Q3 | $42.1M | Sell |
836,028
-21,092
| -2% | -$1.06M | 0.43% | 71 |
|
|
2018
Q2 | $51.3M | Sell |
857,120
-222,668
| -21% | -$13.3M | 0.55% | 44 |
|
|
2018
Q1 | $49.5M | Sell |
1,079,788
-7,627
| -0.7% | -$349K | 0.55% | 47 |
|
|
2017
Q4 | $43.3M | Sell |
1,087,415
-39,803
| -4% | -$1.59M | 0.46% | 66 |
|
|
2017
Q3 | $45.1M | Sell |
1,127,218
-45,647
| -4% | -$1.83M | 0.5% | 58 |
|
|
2017
Q2 | $50.6M | Buy |
1,172,865
+43,007
| +4% | +$1.85M | 0.57% | 46 |
|
|
2017
Q1 | $35.4M | Buy |
1,129,858
+35,981
| +3% | +$1.13M | 0.41% | 71 |
|
|
2016
Q4 | $27.6M | Buy |
1,093,877
+148,520
| +16% | +$3.75M | 0.35% | 88 |
|
|
2016
Q3 | $23.4M | Buy |
945,357
+52,806
| +6% | +$1.31M | 0.4% | 83 |
|
|
2016
Q2 | $18.2M | Buy |
892,551
+110,320
| +14% | +$2.25M | 0.33% | 104 |
|
|
2016
Q1 | $11.9M | Buy |
782,231
+118,482
| +18% | +$1.81M | 0.22% | 155 |
|
|
2015
Q4 | $8.92M | Buy |
663,749
+72,920
| +12% | +$980K | 0.16% | 203 |
|
|
2015
Q3 | $8.29M | Buy |
590,829
+203,875
| +53% | +$2.86M | 0.16% | 207 |
|
|
2015
Q2 | $6.57M | Buy |
+386,954
| New | +$6.57M | 0.12% | 239 |
|